GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Allied Biotech Corp (ROCO:1780) » Definitions » Ending Cash Position

Allied Biotech (ROCO:1780) Ending Cash Position : NT$870.8 Mil (As of Jun. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Allied Biotech Ending Cash Position?

Allied Biotech's Ending Cash Position for the quarter that ended in Jun. 2024 was NT$870.8 Mil.

Allied Biotech's quarterly Ending Cash Position declined from Jun. 2023 (NT$716.4 Mil) to Dec. 2023 (NT$618.5 Mil) but then increased from Dec. 2023 (NT$618.5 Mil) to Jun. 2024 (NT$870.8 Mil).

Allied Biotech's annual Ending Cash Position declined from Dec. 2021 (NT$757.4 Mil) to Dec. 2022 (NT$679.8 Mil) and declined from Dec. 2022 (NT$679.8 Mil) to Dec. 2023 (NT$618.5 Mil).

Allied Biotech Ending Cash Position Historical Data

The historical data trend for Allied Biotech's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allied Biotech Ending Cash Position Chart

Allied Biotech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 408.79 703.48 757.39 679.75 618.49

Allied Biotech Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 777.94 679.75 716.37 618.49 870.83

Allied Biotech Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Allied Biotech's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=679.75+-61.256
=618.5

Allied Biotech's Ending Cash Position for the quarter that ended in Jun. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=618.494+252.338
=870.8

Allied Biotech Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Allied Biotech's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Allied Biotech Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Allied Biotech Corp (ROCO:1780) » Definitions » Ending Cash Position
Comparable Companies
ROCO:6817 TPE:3054 ROCO:4117 ROCO:6496 ROCO:8432 ROCO:6935 ROCO:4172 ROCO:7561 ROCO:4127 ROCO:6677 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
No. 76 Tun Hua S. Road, Sec. 2, 12th Floor, Taipei, TWN
Website
http://www.altratene.com
Allied Biotech Corp is a Taiwan based manufacturer of carotenoids. It manufactures carotenoid formulations for the food, supplement and feed industries. The company markets its products under the name Altratene.

Allied Biotech Headlines

No Headlines